» Articles » PMID: 22663175

Development and Cross-validation of the In-hospital Mortality Prediction in Advanced Cancer Patients Score: a Preliminary Study

Overview
Journal J Palliat Med
Specialty Critical Care
Date 2012 Jun 6
PMID 22663175
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Acute palliative care units (APCUs) provide intensive symptom support and transition of care for advanced cancer patients. Better understanding of the predictors of in-hospital mortality is needed to facilitate program planning and patient care. In this prospective study, we identified predictors of APCU mortality, and developed a four-item In-hospital Mortality Prediction in Advanced Cancer Patients (IMPACT) predictive model.

Methods: Between April and July 2010, we documented baseline demographics, the Edmonton Symptom Assessment Scale (ESAS), 80 clinical signs including known prognostic factors, and 26 acute complications on admission in consecutive APCU patients. Multivariate logistic regression analysis was used to identify factors for inclusion in a nomogram, which was cross-validated with bootstrap analysis.

Results: Among 151 consecutive patients, the median age was 58, 13 (9%) had hematologic malignancies, and 52 (34%) died in the hospital. In multivariate analysis, factors associated with in-hospital mortality were advanced education (odds ration [OR]=11.8, p=0.002), hematologic malignancies (OR=8.6, p=0.02), delirium (OR=4.3, p=0.02), and high ESAS global distress score (OR=20.8, p=0.01). In a nomogram based on these four factors, total scores of 6, 10, 14, 17, and 21 corresponded to a risk of death of 10%, 25%, 50%, 75%, and 90%, respectively. The model has 92% sensitivity and 88% specificity for predicting patients at low/high risk of dying in the hospital, and a receiver-operator characteristic curve concordance index of 83%.

Conclusions: Higher education was associated with increased utilization of the interdisciplinary palliative care unit until at the end of life. Patients with higher symptom burden, delirium, and hematologic malignancies were also more likely to require APCU care until death.

Citing Articles

Engagement, Advance Care Planning, and Hospice Use in a Telephonic Nurse-Led Palliative Care Program for Persons Living with Advanced Cancer.

Yamarik R, Chiu L, Flannery M, Van Allen K, Adeyemi O, Cuthel A Cancers (Basel). 2023; 15(8).

PMID: 37190238 PMC: 10136814. DOI: 10.3390/cancers15082310.


Evaluating High-Dimensional Machine Learning Models to Predict Hospital Mortality Among Older Patients With Cancer.

Qiao E, Qian A, Nalawade V, Voora R, Kotha N, Vitzthum L JCO Clin Cancer Inform. 2022; 6:e2100186.

PMID: 35671416 PMC: 9225681. DOI: 10.1200/CCI.21.00186.


Challenges in virtual collection of patient-reported data: a prospective cohort study conducted in COVID-19 era.

Kazazian K, Bogach J, Johnston W, Ng D, Swallow C Support Care Cancer. 2022; 30(9):7535-7544.

PMID: 35670865 PMC: 9171486. DOI: 10.1007/s00520-022-07191-3.


Data from emergency medicine palliative care access (EMPallA): a randomized controlled trial comparing the effectiveness of specialty outpatient versus telephonic palliative care of older adults with advanced illness presenting to the emergency....

Schmucker A, Flannery M, Cho J, Goldfeld K, Grudzen C BMC Emerg Med. 2021; 21(1):83.

PMID: 34247588 PMC: 8272986. DOI: 10.1186/s12873-021-00478-4.


Could symptom burden predict subsequent healthcare use in patients with end stage kidney disease on hemodialysis care? A prospective, preliminary study.

Zhang J, El-Majzoub S, Li M, Ahmed T, Wu J, Lipman M Ren Fail. 2020; 42(1):294-301.

PMID: 32506997 PMC: 7144228. DOI: 10.1080/0886022X.2020.1744449.


References
1.
Bruera E, Sweeney C, Russell N, Willey J, Palmer J . Place of death of Houston area residents with cancer over a two-year period. J Pain Symptom Manage. 2003; 26(1):637-43. DOI: 10.1016/s0885-3924(03)00204-5. View

2.
Hui D, Elsayem A, Li Z, De La Cruz M, Palmer J, Bruera E . Antineoplastic therapy use in patients with advanced cancer admitted to an acute palliative care unit at a comprehensive cancer center: a simultaneous care model. Cancer. 2010; 116(8):2036-43. PMC: 2854875. DOI: 10.1002/cncr.24942. View

3.
Fadul N, El Osta B, Dalal S, Poulter V, Bruera E . Comparison of symptom burden among patients referred to palliative care with hematologic malignancies versus those with solid tumors. J Palliat Med. 2008; 11(3):422-7. DOI: 10.1089/jpm.2007.0184. View

4.
Hadorn D, Draper D, Rogers W, Keeler E, Brook R . Cross-validation performance of mortality prediction models. Stat Med. 1992; 11(4):475-89. DOI: 10.1002/sim.4780110409. View

5.
Meropol N, Egleston B, Buzaglo J, Benson 3rd A, Cegala D, Diefenbach M . Cancer patient preferences for quality and length of life. Cancer. 2008; 113(12):3459-66. PMC: 2606934. DOI: 10.1002/cncr.23968. View